Titan Pharmaceuticals
TTNP
#10414
Rank
โ‚น0.55 B
Marketcap
โ‚น414.15
Share price
-3.76%
Change (1 day)
31.11%
Change (1 year)

Titan Pharmaceuticals (TTNP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚น23.62 Million

According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น23.62 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น41.43 M-65.53%
2023-12-31โ‚น0.12 B-46.1%
2022-12-31โ‚น0.22 B4.91%
2021-12-31โ‚น0.21 B-36.19%
2020-12-31โ‚น0.33 B-42.25%
2019-12-31โ‚น0.57 B13.57%
2018-12-31โ‚น0.50 B-1.16%
2017-12-31โ‚น0.51 B38.09%
2016-12-31โ‚น0.37 B-11.08%
2015-12-31โ‚น0.41 B-46.06%
2014-12-31โ‚น0.77 B-0.84%
2013-12-31โ‚น0.78 B-70.21%
2012-12-31โ‚น2.62 B63.83%
2011-12-31โ‚น1.60 B231.01%
2010-12-31โ‚น0.48 B165.31%
2009-12-31โ‚น0.18 B
2007-12-31โ‚น0.16 B11.11%
2006-12-31โ‚น0.15 B6.52%
2005-12-31โ‚น0.14 B-11.26%
2004-12-31โ‚น0.15 B4.54%
2003-12-31โ‚น0.15 B-19.59%
2002-12-31โ‚น0.18 B-31.98%
2001-12-31โ‚น0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
โ‚น12.14 B 51,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
โ‚น0.26 B 1,028.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น4.49 B 18,940.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.199 T 43,170,622.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.618 T 23,778,227.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
โ‚น75.51 B 319,528.90%๐Ÿ‡บ๐Ÿ‡ธ USA